This week CMS unveiled its proposed rule to overhaul Medicaid managed care and folded to Florida Governor Rick Scott, and the American Society of Clinical Oncology kicks off its annual meeting in Chicago.
A massive overhaul is planned for Medicaid managed care for the first time since 2002 as CMS unveiled its proposed rule this week. Andy Slavitt, acting administrator for CMS, said the proposal's 3 main aims are to improve transparency and consumer protections; provide better care coordination; and allow states to pursue delivery system reforms.
In Florida, Governor Rick Scott scored a victory over CMS. The agency agreed to continue funding Florida's Low-Income Pool, the program that pays for uncompensated hospital care. However, the structure of the $1 billion deal still makes Medicaid expansion the best option for the long haul.
In this month's issue of The American Journal of Managed Care the special guest commentary comes from Christine Cassel, MD, the president and chief executive officer of the National Quality Forum, who wrote on meaningful measurement and driving greater value in healthcare. In addition, researchers from the Brookings Institute examined 4 alternative payment models for oncology care that shift away from fee-for-service.
Finally, just before ASCO's annual meeting kicked off, the society announced its new patient-centered oncology payment model, which addresses issues such as education and support to help patients make the best treatment decision, and continued support to patients after active treatment ends. The 2015 annual meeting runs May 29 to June 3 and The American Journal of Managed Care is there interviewing experts and covering session. You can follow our conference coverage here.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More